【24h】

Is geriatric assessment adapted to radiotherapy?

机译:老年评估是否适合放疗?

获取原文
获取原文并翻译 | 示例
       

摘要

Cancer in the elderly represents a major public health topic and its importance will increase in the future because of increased life expectancy and ageing. Cancer prognosis is worse due to late diagnosis, frequent comorbidities and treatment often considered as suboptimal. Reference treatments were primarily validated for younger or selected elderly patients and experimental data collected on most vulnerable are rare. Oncogeriatrics development for 15 years made it possible to consider two fundamental aspects, which are the geriatric evaluation, from the most simple to the complete one, and the development of specific trials. In addition, a strong institutional policy allowed promotion, on the French national territory, of regional experiments thanks to Pilot Units of Oncogeriatrics Coordination (UPCOG). The question of the interest of a geriatric evaluation in radiotherapy is related mainly to the difficulties of tolerance and observance of this treatment, but also with its effectiveness and this review explores the main curative, adjuvant and palliative indications as well as research perspectives.
机译:老年人癌症是一个主要的公共卫生话题,并且由于预期寿命的增加和年龄的增长,其重要性在未来将不断提高。由于晚期诊断,频繁合并症和通常被认为次优的治疗,癌症的预后更差。参考疗法主要针对年轻或选定的老年患者进行验证,关于最脆弱人群的实验数据很少。 15年的老年医学发展使得可以考虑两个基本方面,即从最简单到完整的老年医学评估以及特定试验的开发。此外,得益于肿瘤老年医学协调试点(UPCOG),一项强有力的机构政策允许在法国国家领土上推广区域试验。放射治疗中对老年医学评估感兴趣的问题主要与该治疗的耐受性和遵守难度有关,但也与它的有效性有关,本综述探讨了主要的治疗,辅助和姑息适应症以及研究前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号